Stock Trends Insights: Bullish Momentum in Consumer Discretionary and Healthcare

These opportunities emerge from our weekly evaluation of all listed stocks, filtered through indicators such as Bullish Crossover, Bullish, and RSI Outperformance. The current distribution shows strength in select growth-oriented segments even as broader market breadth remains moderate — a signal profile consistent with the “bullish recovery epoch” we have identified in our Stock Trends ML Project’s epoch analysis. This epoch reflects improving intermediate-term breadth and increasing trend maturity in leadership sectors, suggesting sustained upside potential.

Consumer Discretionary: Early Breakouts

The Stock Trends Early Breakout classification highlights stocks where the 13-week moving average has recently crossed above the 40-week average, with additional confirmation from price momentum and volume patterns. In Consumer Discretionary, two stocks stand out from this week’s screeners:

Symbol	Company	Trend Classification	Key Stock Trends Indicators
FLYE-Q	Fly-E Group Inc.	Bullish	13w MA above 40w MA, Rising RSI, Positive Volume Tag
MRM-Q	MEDIROM Healthcare Technologies Inc.	Bullish	Breakout on rising volume, RSI > 100, strong ST-IM 13-week estimate

Fly-E Group Inc. (FLYE-Q) — The Stock Trends Bullish Crossover at the end of June coincided with a decisive technical shift backed by positive volume momentum. There has been eight consecutive weeks of the stock being tagged with the unusually high volume indicator (). Fundamentally, Fly-E has accelerated its expansion by opening its first retail store in Mexico City in partnership with local e-mobility brand E-Solomo, tapping into the growing Latin American e-bike market. The company’s recent resolution of Nasdaq compliance issues via a reverse split has removed a major overhang, allowing the breakout signal to play out without structural market risk.

MEDIROM Healthcare Technologies Inc. (MRM-Q) — MEDIROM’s Bullish Crossover at the beginning of August reflects both improving price action and a current strong ST-IM profile. Fundamentally, MEDIROM’s core wellness salon business posted 21–22% revenue growth in 2024, and the company recently announced a partnership with Tools for Humanity to integrate Worldcoin’s biometric “World ID” verification into 100 salons by year-end. This unusual catalyst has fueled speculative interest, aligning with the breakout profile our indicators flagged.

Healthcare: Established Bullish Trends

Stocks in this classification have been in bullish mode for multiple weeks, often supported by a mature uptrend and consistent RSI outperformance. The current ST-IM estimates and indicator distributions show Healthcare as one of the most resilient sectors in the current epoch. Four names exemplify this trend:

Symbol	Company	Trend Classification	Key Stock Trends Indicators
OPRX-Q	OptimizeRx Corporation	Bullish	Multi-week RSI outperformance, Positive Volume Tag, High ST-IM estimates
ADPT-Q	Adaptive Biotechnologies Corp.	Bullish	Strong trend maturity, RSI > 100, Consistent ST-IM top quartile
ABVC-Q	ABVC BioPharma Inc.	Bullish	Trend Age > 10 weeks, Positive Volume
EPRX-Q	Eupraxia Pharmaceuticals Inc.	Bullish	Confirmed RSI strength, Long-term MA alignment, Positive Volume Tag

OptimizeRx (OPRX-Q) — The bullish continuation pattern here is confirmed by a 55% YoY revenue surge in Q2 2025 and a swing to profitability. Raised full-year guidance and analyst upgrades strengthen the technical case our indicators flagged.

Adaptive Biotechnologies (ADPT-Q) — A strong RSI and multi-week trend age reflect the company’s expanding adoption of its MRD cancer tests, with revenue growth of 36% YoY. The raised guidance for its MRD segment supports the trend our system has captured.

ABVC BioPharma (ABVC-Q) — Positive volume signals align with a steady uptrend fueled by Phase II success for its lead antidepressant candidate and ongoing licensing revenues from oncology and ophthalmology partnerships.

Eupraxia Pharmaceuticals (EPRX-Q) — Long-term MA alignment and confirmed RSI outperformance reflect the stock’s momentum following Phase 2b success in osteoarthritis and encouraging mid-stage results in eosinophilic esophagitis. Upcoming trial data remain key catalysts.

Putting It Together

In this week’s data, the Stock Trends indicators don’t just identify individual stocks — they highlight where the leadership is forming in the market. Our ML Project’s epoch analysis has shown that such concentrated sector leadership, paired with improving breadth, is characteristic of sustainable intermediate-term uptrends. This week’s Consumer Discretionary and Healthcare leadership fits that profile.

For investors, these stocks are not mere watchlist candidates — they are case studies in how technical strength, as defined by Stock Trends indicators, often coincides with fundamental catalysts and sector tailwinds. Combining indicator-driven selection with informed research can help capture momentum early and manage risk effectively.